VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 142 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $339,000 | -15.7% | 29,640 | -23.5% | 0.02% | -28.0% |
Q1 2020 | $402,000 | -31.4% | 38,760 | +8.6% | 0.02% | +8.7% |
Q4 2019 | $586,000 | +4.3% | 35,705 | -15.6% | 0.02% | -8.0% |
Q3 2019 | $562,000 | -40.3% | 42,295 | -36.7% | 0.02% | -32.4% |
Q2 2019 | $941,000 | -50.6% | 66,815 | -44.0% | 0.04% | +23.3% |
Q4 2016 | $1,904,000 | -4.8% | 119,380 | -0.7% | 0.03% | +7.1% |
Q3 2016 | $2,000,000 | – | 120,205 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,532,000 | $27,423,000 | 3.23% |
Stonepine Capital Management, LLC | 300,000 | $5,370,000 | 3.16% |
Palo Alto Investors LP | 4,155,670 | $74,386,000 | 3.13% |
GREAT POINT PARTNERS LLC | 497,531 | $8,906,000 | 1.73% |
Avoro Capital Advisors LLC | 988,270 | $17,690,000 | 1.37% |
UNIVERSITY OF NOTRE DAME DU LAC | 157,781 | $2,824,000 | 0.79% |
Birchview Capital, LP | 68,000 | $1,217,000 | 0.63% |
Cheyne Capital Management (UK) LLP | 74,000 | $1,323,000 | 0.48% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 352,604 | $6,311,000 | 0.43% |
361 CAPITAL LLC | 119,554 | $2,140,000 | 0.41% |